Literature DB >> 15560116

The induction of prostaglandin E synthase and upregulation of cyclooxygenase-2 by 9-cis retinoic acid.

Hiroki Tsukamoto1, Takanori Hishinuma, Risa Tayama, Kaori Narahara, Naoto Suzuki, Yoshihisa Tomioka, Junichi Goto.   

Abstract

9-cis Retinoic acid (9cRA) is a promising lead compound to design the retinoid X receptor (RXR) ligands with the ability to simultaneously activate RXR heterodimers with the selectivity to their nuclear receptor partners. In this study, we investigated the effects of 9cRA on the prostaglandin E2 (PGE2) and thromboxane A2 (TXA2) production. 9cRA increased the PGE2 and TXA2 productions in the presence of lipopolysaccharide (LPS). All-trans retinoic acid, the retinoic acid receptor ligand, also increased their production. We revealed that cyclooxygenase (COX)-2 was clearly induced by 9cRA in the presence of LPS. The induction was not suppressed by indomethacin, which completely inhibited the increase in the LPS-stimulated prostanoid production by 9cRA. The expression levels of the toll-like receptor 4 and CD14, which were components of the LPS receptor complex, were increased by 9cRA in the presence and absence of LPS. PGE synthase was also clearly increased by 9cRA in the presence and absence of LPS. In this study, we noted that 9cRA increased the production of PGE2 and TXA2 by the induction of COX-2 and PGE synthase in the presence of LPS. The induction of the LPS receptor complex by 9cRA is able to upregulate the induction of COX-2 by LPS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15560116     DOI: 10.1016/j.prostaglandins.2004.07.001

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  3 in total

1.  Kinase-dependent, retinoic acid receptor-independent up-regulation of cyclooxygenase-2 by all-trans retinoic acid in human mesangial cells.

Authors:  M Alique; V Moreno; M Kitamura; Q Xu; F J Lucio-Cazana
Journal:  Br J Pharmacol       Date:  2006-08-07       Impact factor: 8.739

2.  An agonistic anti-Toll-like receptor 4 monoclonal antibody as an effective adjuvant for cancer immunotherapy.

Authors:  Hiroki Tsukamoto; Kanae Kubota; Ayumi Shichiku; Masamitsu Maekawa; Nariyasu Mano; Hideo Yagita; Shoichiro Ohta; Yoshihisa Tomioka
Journal:  Immunology       Date:  2019-10       Impact factor: 7.397

3.  All-trans retinoic acid induces COX-2 and prostaglandin E2 synthesis in SH-SY5Y human neuroblastoma cells: involvement of retinoic acid receptors and extracellular-regulated kinase 1/2.

Authors:  Matilde Alique; Juan F Herrero; Francisco Javier Lucio-Cazana
Journal:  J Neuroinflammation       Date:  2007-01-04       Impact factor: 8.322

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.